Economics of Health and Health Care / Edition 6

Economics of Health and Health Care / Edition 6

ISBN-10:
0136080308
ISBN-13:
9780136080305
Pub. Date:
08/14/2009
Publisher:
Prentice Hall

Hardcover

View All Available Formats & Editions
Current price is , Original price is $220.0. You
Select a Purchase Option (Older Edition)
  • purchase options
    $46.95 $220.00 Save 79% Current price is $46.95, Original price is $220.0. You Save 78.6590909090909%.
    • Free return shipping at the end of the rental period details
    • Textbook Rentals in 3 Easy Steps  details
    icon-error
    Note: Access code and/or supplemental material are not guaranteed to be included with textbook rental or used textbook.
  • purchase options
    $102.85 $220.00 Save 53% Current price is $102.85, Original price is $220. You Save 53%.
    icon-error
    Note: Access code and/or supplemental material are not guaranteed to be included with textbook rental or used textbook.
  • purchase options

Overview

Economics of Health and Health Care / Edition 6

NEW TO THIS EDITION

  • Totally re-written chapter on managed care.
  • New analyses on "who pays" for health insurance.
  • New chapter on economic "bads" (Chapter 25). Most analyses look at things that are good for us - "bad" items such as cigarettes are usually not covered.
  • New chapter on pharmaceuticals (Chapter 26). Rather than a simple "industry study," the text examines portions of the pharmaceutical industry with important economic content. These include questions as to the optimal combinations of drug therapies and other economic technologies, patent protection issues, and price discrimination by pharmaceutical firms.

For more information visit us at www.prenhall.com/folland

Product Details

ISBN-13: 9780136080305
Publisher: Prentice Hall
Publication date: 08/14/2009
Series: Pearson Custom Business Resources Series
Edition description: Older Edition
Pages: 648
Product dimensions: 8.10(w) x 10.00(h) x 1.20(d)

About the Author

Sherman Folland is Professor of Economics (emeritus) at Oakland University in Rochester, Michigan, USA. He received his PhD from The University of Iowa in 1975 and has taught at Penn State University and Oakland University. He has written over 50 articles and edited several books.

Allen C. Goodman is Professor of Economics at Wayne State University in Detroit, Michigan, USA. He received his PhD from Yale University and has taught at Lawrence University, The Johns Hopkins University, and Wayne State. He has written over 100 articles and three books in health and housing economics.

Miron Stano is Professor of Economics and Management at Oakland University in Rochester, Michigan, USA. He received his PhD from Cornell University in 1971 and has taught at Wayne State University and Oakland University. He has written over 100 articles and has also served as an expert witness in antitrust cases involving the health care professions.

Read an Excerpt

PREFACE:

Preface

This is the third edition of a book that was conceived in 1990 and first published in 1993. To indicate how much the world of health economics has changed, the first edition made a single reference to "managed care," and that was in the context of monopoly power in the provision of health care. In addition, the debate on the Clinton health plan illuminated a large set of issues that invigorated the discipline of health economics.

This book was first written to assist health economics instructors in developing a clear, step-by-step understanding of health economics for their students. We also believe that it is important for instructors to show what health economics researchers are doing in theory and in empirical work. The book synthesizes contemporary developments around a set of basic economic principles, including maximization of consumer utility (or well-being) and economic profit, wishing to make these principles accessible to undergraduate students, as well as to graduate students. Rather than organizing the book around the institutions specific to the health care economy, we have used core economics themes as basic as supply and demand, as venerable as technology or labor issues, and as modern as the economics of information. Moreover, we have sought to improve accessibility to the book for the wide range of health services students and practitioners whose knowledge of economics may be more limited.

We have followed the philosophy that students must have a working knowledge of the analytical tools of economics and econometrics to appreciate the field of health economics. Some students may be ready to plunge directly intoCost-Benefit Analysis (chapter 4) or The Production of Health (chapter 5) upon completion of the introductory chapter 1. However, chapters 2 (Microeconomic Tools) and 3 (Statistical Tools) allow the students and their teachers to develop or to review the needed analytical concepts before tackling the core subject matter. In chapters 2 and 3, students with as little as one semester of microeconomics may review and study how economists analyze problems, using examples that are relevant to health economics. No calculus is needed.

Consistent with an emphasis on clarity of exposition, this book makes extensive use of graphs, tables, and charts. Discussion questions and exercises are provided to help students master the basics and to prompt them to think about the issues. Features on up-to-date applications of theory and policy developments are also included, as well as the occasional tidbit containing purely background information.

Finally, we caution that some of the chapters, such as those on insurance, although devoid of advanced mathematics, may still require considerable effort. No painless way is available to appreciate the scope of the contributions that scholars have made in recent years. Sections or subsections that are more demanding and/or peripheral to the core material have been identified. These sections can be omitted without detracting from the flow of the book. More advanced students of the health care economy who wish to be challenged further can utilize a comprehensive references section, with more than 750 sources, so that their (and our) work can be enriched through referral to the original sources.

What's Changed in the Third Edition?

It is critical that this textbook contain the most current knowledge and address the needs of our readers. As with the second edition, almost every chapter is revised to incorporate significant developments in the field.

In response to the instructors and students who use this book, we have moved the chapter on cost-benefit analysis forward, so that it is now chapter 4. We have made major changes in the treatment of insurance and managed care. Also in response to user demand, we have broken up a single health insurance chapter into two components. Insurance (chapter 7), which looks at the individual determinants of insurance, now precedes Consumer Choice (chapter 8), as well as a set of chapters on important, related economic topics. The Organization of Health Insurance Markets (chapter 11), which looks at the development of health insurance markets (and asks the question "who pays?"), precedes the entirely rewritten and greatly expanded chapter on Managed Care (chapter 12). In this chapter, we make a major effort to link theoretical models and empirical findings.

The section on governmental actions regarding the health economy has been reorganized. Chapter 20 looks at conceptual issues regarding government intervention in health care markets; chapter 21 investigates the principal regulatory mechanisms, including antitrust policy. These are followed by an updated chapter 22, which includes information about the 1997 changes to Medicare and Medicaid.

Finally, we finish the book with two new chapters. Chapter 25 looks at economic "bads." Economists like to look at things that are good for us, but some things such as cigarettes are not. Chapter 26 is an entirely new chapter on pharmaceuticals. Rather than a simple "industry study," we look at those portions of the pharmaceutical industry with particularly novel economic contents. These include questions as to the optimal combinations of drug therapies and other economic technologies, the appropriate amount of patent protection that an industry (in this case the pharmaceutical industry) should enjoy, and price discrimination by pharmaceutical firms (or why drugs are cheaper in Mexico than in the United States).

Another change involves the emergence of Internet resources for students and scholars. Tables and charts that were once available only in book form, and then only after several years, are now available much more quickly, and are often available on the Internet long before they are available (if at all) in print. The downside to this explosion of information involves editorial oversight (not all sources are good ones) and frustrating tendencies for Internet sites to disappear. We have chosen to focus on governmental sites such as the following for references that we believe to be both long lasting and reliable.

National Institutes of Health (...

Table of Contents

I. BASIC ECONOMIC TOOLS.

1. Introduction.
2. Microeconomic Tools.
3. Statistical Tools.
4. Cost-Benefit Analysis and Other Tools of Economic Evaluation.

II. SUPPLY AND DEMAND.

5. The Production of Health.
6. Demand for Health Capital.
7. Insurance.
8. Consumer Choice and Demand.

III. INFORMATION.

9. Asymmetric Information and Agency.
10. Imperfect Information: SID and SAV.

IV. INSURANCE AND ORGANIZATION OF HEALTH PROVIDERS.

11. The Organization of Health Insurance Markets.
12. Managed Care.

V. TECHNOLOGY.

13. The Production and Cost of Health Care.
14. Technology.

VI. LABOR.

15. Labor Markets and Professional Training.
16. The Training and Practice of Physicians.

VII. HOSPITALS AND NURSING HOMES.

17. Nonprofit Firms.
18. Hospitals and Long Term Care.

VIII. SOCIAL INSURANCE AND HEALTH SYSTEM REFORM.

19. Equity, Efficiency and Need.
20. Government Intervention.
21. Government Regulation.
22. Social Insurance.
23. Comparative Health Care Systems.

IX. POLICY ISSUES AND ANALYSES.

24. Health Systems Reform.
25. Advertising, Health Goods and Bads.
26. The Pharmaceutical Industry.

Preface

PREFACE:

Preface

This is the third edition of a book that was conceived in 1990 and first published in 1993. To indicate how much the world of health economics has changed, the first edition made a single reference to "managed care," and that was in the context of monopoly power in the provision of health care. In addition, the debate on the Clinton health plan illuminated a large set of issues that invigorated the discipline of health economics.

This book was first written to assist health economics instructors in developing a clear, step-by-step understanding of health economics for their students. We also believe that it is important for instructors to show what health economics researchers are doing in theory and in empirical work. The book synthesizes contemporary developments around a set of basic economic principles, including maximization of consumer utility (or well-being) and economic profit, wishing to make these principles accessible to undergraduate students, as well as to graduate students. Rather than organizing the book around the institutions specific to the health care economy, we have used core economics themes as basic as supply and demand, as venerable as technology or labor issues, and as modern as the economics of information. Moreover, we have sought to improve accessibility to the book for the wide range of health services students and practitioners whose knowledge of economics may be more limited.

We have followed the philosophy that students must have a working knowledge of the analytical tools of economics and econometrics to appreciate the field of health economics. Some students may be ready to plunge directlyintoCost-Benefit Analysis (chapter 4) or The Production of Health (chapter 5) upon completion of the introductory chapter 1. However, chapters 2 (Microeconomic Tools) and 3 (Statistical Tools) allow the students and their teachers to develop or to review the needed analytical concepts before tackling the core subject matter. In chapters 2 and 3, students with as little as one semester of microeconomics may review and study how economists analyze problems, using examples that are relevant to health economics. No calculus is needed.

Consistent with an emphasis on clarity of exposition, this book makes extensive use of graphs, tables, and charts. Discussion questions and exercises are provided to help students master the basics and to prompt them to think about the issues. Features on up-to-date applications of theory and policy developments are also included, as well as the occasional tidbit containing purely background information.

Finally, we caution that some of the chapters, such as those on insurance, although devoid of advanced mathematics, may still require considerable effort. No painless way is available to appreciate the scope of the contributions that scholars have made in recent years. Sections or subsections that are more demanding and/or peripheral to the core material have been identified. These sections can be omitted without detracting from the flow of the book. More advanced students of the health care economy who wish to be challenged further can utilize a comprehensive references section, with more than 750 sources, so that their (and our) work can be enriched through referral to the original sources.

What's Changed in the Third Edition?

It is critical that this textbook contain the most current knowledge and address the needs of our readers. As with the second edition, almost every chapter is revised to incorporate significant developments in the field.

In response to the instructors and students who use this book, we have moved the chapter on cost-benefit analysis forward, so that it is now chapter 4. We have made major changes in the treatment of insurance and managed care. Also in response to user demand, we have broken up a single health insurance chapter into two components. Insurance (chapter 7), which looks at the individual determinants of insurance, now precedes Consumer Choice (chapter 8), as well as a set of chapters on important, related economic topics. The Organization of Health Insurance Markets (chapter 11), which looks at the development of health insurance markets (and asks the question "who pays?"), precedes the entirely rewritten and greatly expanded chapter on Managed Care (chapter 12). In this chapter, we make a major effort to link theoretical models and empirical findings.

The section on governmental actions regarding the health economy has been reorganized. Chapter 20 looks at conceptual issues regarding government intervention in health care markets; chapter 21 investigates the principal regulatory mechanisms, including antitrust policy. These are followed by an updated chapter 22, which includes information about the 1997 changes to Medicare and Medicaid.

Finally, we finish the book with two new chapters. Chapter 25 looks at economic "bads." Economists like to look at things that are good for us, but some things such as cigarettes are not. Chapter 26 is an entirely new chapter on pharmaceuticals. Rather than a simple "industry study," we look at those portions of the pharmaceutical industry with particularly novel economic contents. These include questions as to the optimal combinations of drug therapies and other economic technologies, the appropriate amount of patent protection that an industry (in this case the pharmaceutical industry) should enjoy, and price discrimination by pharmaceutical firms (or why drugs are cheaper in Mexico than in the United States).

Another change involves the emergence of Internet resources for students and scholars. Tables and charts that were once available only in book form, and then only after several years, are now available much more quickly, and are often available on the Internet long before they are available (if at all) in print. The downside to this explosion of information involves editorial oversight (not all sources are good ones) and frustrating tendencies for Internet sites to disappear. We have chosen to focus on governmental sites such as the following for references that we believe to be both long lasting and reliable.

National Institutes of Health (...

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews